Delivery Order SPE2DB22D2007-SPE2DB24FJ5AU
Award Date
8/13/24
Potential Completion Date
9/4/24
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML. The $8,504.62 firm-fixed-price contract has an ultimate completion date of April 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of TECENTRIQ 840 MG/14 ML VIAL 14ML, a specialty pharmaceutical product. The contract has a potential value of $24,048.90 and a completion date of February 21, 2024. This delivery order contract is issued under an...
This is a delivery order (SPE2DB20D1100|SPE2DB24FA7E7) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The order is for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML, a specialty pharmaceutical product, at a firm fixed price of $16,032.60. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML medical products. The contract has a ceiling value of $7,857.74 and a performance period running through January 18, 2024. The contract is a firm fixed-price delivery order, and does not have a set-aside designation. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., one of the...
This federal contract award, valued at $17,009.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TECENTRIQ 840 MG/14 ML VIAL 14ML, a specialty medication, to support military healthcare programs. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of 840 mg/14 mL vials of the drug TECENTRIQ. The contract has a potential value of $24,048.90 and a period of performance through March 25, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which does not have any set-aside designation. Additionally,...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 840 mg/14 ml vials of the pharmaceutical product Tecentriq, with a potential value of $4,008.15 and a completion date of March 20, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will provide this medication to support military treatment programs and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 840 mg/14 ml vials of the cancer medication Tecentriq. The $8,504.62 firm fixed-price delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides comprehensive global pharmaceutical support to military healthcare programs. The contract is not...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TECENTRIQ 840 MG/14 ML VIAL 14ML. This $8,016.30 contract has a completion date of March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors mentioned. The contract was awarded through DLA Troop Support Medical, which is responsible for supplying pharmaceuticals, medical...
This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $7,857.74 firm fixed price delivery order is for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML, a pharmaceutical product. The contract has a completion date of January 23, 2024 and was awarded on December 29, 2023. No set-aside designations were used. Amerisourcebergen Drug Corp is a prime...